Reaction
Reticulocyte Count Abnormal reporting signals
As of the last recalculation, Reticulocyte Count Abnormal appears in 112 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 146.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 31 | 146.2 | 146.3 |
| Voxelotor | 8 | 71.3 | 71.3 |